ATE292460T1 - Zusammenstellungen die aktive stilbenoidverbindungen enthalten zur senkung des triglyceridspiegels - Google Patents

Zusammenstellungen die aktive stilbenoidverbindungen enthalten zur senkung des triglyceridspiegels

Info

Publication number
ATE292460T1
ATE292460T1 AT01962156T AT01962156T ATE292460T1 AT E292460 T1 ATE292460 T1 AT E292460T1 AT 01962156 T AT01962156 T AT 01962156T AT 01962156 T AT01962156 T AT 01962156T AT E292460 T1 ATE292460 T1 AT E292460T1
Authority
AT
Austria
Prior art keywords
triglyceride levels
compositions containing
containing active
lowering triglyceride
compounds
Prior art date
Application number
AT01962156T
Other languages
English (en)
Inventor
Wayne D Inman
David Craig Hoppe
Original Assignee
Insmed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insmed Inc filed Critical Insmed Inc
Application granted granted Critical
Publication of ATE292460T1 publication Critical patent/ATE292460T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Seasonings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Optical Head (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01962156T 2000-08-16 2001-08-15 Zusammenstellungen die aktive stilbenoidverbindungen enthalten zur senkung des triglyceridspiegels ATE292460T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22570400P 2000-08-16 2000-08-16
US09/920,304 US6541522B2 (en) 2000-08-16 2001-08-02 Methods of using compositions containing hypotriglyceridemically active stilbenoids
PCT/US2001/025383 WO2002013806A2 (en) 2000-08-16 2001-08-15 Compositions containing hypotriglyceridemically active stilbenoids

Publications (1)

Publication Number Publication Date
ATE292460T1 true ATE292460T1 (de) 2005-04-15

Family

ID=26919840

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01962156T ATE292460T1 (de) 2000-08-16 2001-08-15 Zusammenstellungen die aktive stilbenoidverbindungen enthalten zur senkung des triglyceridspiegels

Country Status (6)

Country Link
US (1) US6541522B2 (de)
EP (1) EP1311258B1 (de)
AT (1) ATE292460T1 (de)
AU (1) AU2001283355A1 (de)
DE (1) DE60109938T2 (de)
WO (1) WO2002013806A2 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552085B2 (en) 2000-08-16 2003-04-22 Insmed Incorporated Compositions containing hypoglycemically active stilbenoids
US20020058708A1 (en) * 2000-08-16 2002-05-16 Inman Wayne D. Compositions containing hypotriglyceridemically active stilbenoids
US6410596B1 (en) * 2000-08-16 2002-06-25 Insmed Incorporated Compositions containing hypoglycemically active stillbenoids
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US20050080024A1 (en) * 2002-08-15 2005-04-14 Joseph Tucker Nitric oxide donating derivatives for the treatment of cardiovascular disorders
US20050080021A1 (en) * 2002-08-15 2005-04-14 Joseph Tucker Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
US20060025337A1 (en) * 2003-07-01 2006-02-02 President And Fellows Of Harvard College Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
JP2007530417A (ja) * 2003-07-01 2007-11-01 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 細胞及び生物の寿命及びストレス応答を操作するための組成物
US20050171027A1 (en) 2003-12-29 2005-08-04 President And Fellows Of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
AR047658A1 (es) 2004-02-03 2006-02-01 Cargill Inc Concentrado de proteinas y corriente acuosa con carbohidratos hidrosolubles
US20060084085A1 (en) * 2004-06-16 2006-04-20 Sinclair David A Methods and compositions for modulating Bax-mediated apoptosis
US20060014705A1 (en) * 2004-06-30 2006-01-19 Howitz Konrad T Compositions and methods for selectively activating human sirtuins
WO2006045010A2 (en) * 2004-10-20 2006-04-27 Resverlogix Corp. Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
WO2006138418A2 (en) * 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
US20070149466A1 (en) * 2005-07-07 2007-06-28 Michael Milburn Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
US8410109B2 (en) * 2005-07-29 2013-04-02 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
US20070029101A1 (en) * 2005-08-05 2007-02-08 Paul Croas Hammerhead forcible entry tool used to defeat burglar bars
JPWO2008075528A1 (ja) * 2006-12-20 2010-04-08 株式会社黒姫和漢薬研究所 甘茶の用途
PT2118074E (pt) * 2007-02-01 2014-03-20 Resverlogix Corp Compostos para a prevenção e tratamento de doenças cardiovasculares
US7824714B2 (en) * 2008-06-13 2010-11-02 Development Center For Biotechnology Chinese herb extract for treating dementia and preparation method thereof
SI2346837T1 (sl) 2008-06-26 2015-05-29 Resverlogix Corporation Postopki pripravljanja kinazolinonskih derivatov
US8952021B2 (en) 2009-01-08 2015-02-10 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
KR101913109B1 (ko) 2009-03-18 2018-10-31 리스버로직스 코퍼레이션 신규한 소염제
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
US8815310B2 (en) * 2011-01-10 2014-08-26 Morteza Naghavi Compositions for boosting metabolism, assisting weight loss, and promoting cardiovascular health
CA2851996C (en) 2011-11-01 2020-01-07 Resverlogix Corp. Pharmaceutical compositions for substituted quinazolinones
CN105030750B (zh) * 2011-12-23 2018-08-28 中国医学科学院医药生物技术研究所 一组木豆素结构类似化合物在抗丙肝病毒和抗艾滋病毒的应用
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
JP2016507496A (ja) 2012-12-21 2016-03-10 ゼニス・エピジェネティクス・コーポレイションＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｃｏｒｐ． ブロモドメイン阻害剤としての新規複素環式化合物
EP2801357A1 (de) * 2013-05-10 2014-11-12 IMD Natural Solutions GmbH Carboxylierte Stilbene zur Aktivierung von AMPK und Sirtuinen
CN103992290B (zh) * 2013-05-14 2016-07-06 中国医学科学院医药生物技术研究所 二芳基乙烯结构类似化合物及其制备方法和应用
CN104547001A (zh) * 2015-01-09 2015-04-29 刘长河 一种从木豆叶中提取抗骨质疏松和降脂物的工艺
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
WO2018233841A1 (de) * 2017-06-22 2018-12-27 Symrise Ag Geschmacksmodulierende aromastoffe
CN112175856B (zh) * 2019-07-05 2022-10-21 中粮生物科技股份有限公司 用于枯草芽孢杆菌发酵的固体培养基以及枯草芽孢杆菌固体菌剂及其制备方法和应用
EP4240342B1 (de) * 2020-11-05 2026-04-29 Société des Produits Nestlé S.A. Substituierte resorcylsäure-verbindungen als ampk-aktivator und deren verwendung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62270529A (ja) * 1986-05-19 1987-11-24 Nippon Haipotsukusu:Kk 抗アレルギ−剤
US5827898A (en) 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
FR2778337B1 (fr) 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
CA2352585A1 (en) 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
DE10015525A1 (de) 2000-03-30 2001-10-11 Deutsches Krebsforsch Synthetische Derivate von Lunularsäure, Arzneimittel enthaltend diese Verbindung, Verfahren zur Herstellung der Lunularsäurederivate sowie deren Verwendung
US20020058708A1 (en) 2000-08-16 2002-05-16 Inman Wayne D. Compositions containing hypotriglyceridemically active stilbenoids
US6552085B2 (en) 2000-08-16 2003-04-22 Insmed Incorporated Compositions containing hypoglycemically active stilbenoids
US6410596B1 (en) 2000-08-16 2002-06-25 Insmed Incorporated Compositions containing hypoglycemically active stillbenoids

Also Published As

Publication number Publication date
DE60109938T2 (de) 2005-09-08
AU2001283355A1 (en) 2002-02-25
US6541522B2 (en) 2003-04-01
DE60109938D1 (de) 2005-05-12
EP1311258A2 (de) 2003-05-21
WO2002013806A3 (en) 2002-10-31
EP1311258B1 (de) 2005-04-06
US20020055541A1 (en) 2002-05-09
WO2002013806A2 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
ATE292460T1 (de) Zusammenstellungen die aktive stilbenoidverbindungen enthalten zur senkung des triglyceridspiegels
CA2331395A1 (en) Fatty acid analogues for the treatment of diabetes
AU2001283353A1 (en) Compositions containing hypoglycemically active stilbenoids
WO2001081310A8 (en) 1-aroyl-piperidinyl benzamidines
WO2002014252A3 (en) Compositions containing hypoglycemically active stilbenoids
WO2003013497A1 (en) Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
UY27320A1 (es) Nuevas composiciones farmacéuticas
AR100291A2 (es) Composición catártica
EA200100249A1 (ru) 4-аминозамещенные-2-замещенные-1,2,3,4-тетрагидрохинолины в качестве ингибиторов сетр (хэпб)
MA25809A1 (fr) Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase
WO2003082798A8 (es) Compuestos naturales y derivados de éstos para la prevención y el tratamiento de enfermedades cardiovasculares, hepáticas, renales y para aplicaciones cosméticas
IS4695A (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar
ATE311844T1 (de) Nicht-irritierende zusammensetzung zur behandlung des aknes und andere hautzustände
BG103656A (en) Fluoroether compositions and methods for their decomposition inhibition in the presence of lewis acid
BG102383A (bg) Антимикробни състави,съдържащи с долу 3-с долу 6алкохол
NZ327014A (en) Disinfecting compositions containing peroxygen bleach, a betaine or sulphobetaine surfactant and antimicrobial compound
DE60134472D1 (de) Oxidationsverfahren zur herstellung des zwischenproduktes 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpone 17.beta.-karbonsäure
TNSN99013A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
ATE406903T1 (de) Zusammensetzung und ihre verwendungszwecke zur bekämpfung von kater
WO2002013809A3 (en) Compositions containing hypotriglyceridemically active stilbenoids
PT1063886E (pt) Composicao desinfectante
DE60230155D1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
PT100619A (pt) Composicoes farmaceuticas
ATE331824T1 (de) Mittel zur korrosionsverhütung
BR0109139B1 (pt) composiÇÕes farmacÊuticas incluindo alginatos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1311258

Country of ref document: EP

REN Ceased due to non-payment of the annual fee